← Back to Clinical Trials
Recruiting NCT06751160

NCT06751160 Comparative Effects of Dry Needling Versus Soft Tissue Mobilization on Hamstring Tightness

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06751160
Status Recruiting
Phase
Sponsor Riphah International University
Condition Hamstring Tightness
Study Type INTERVENTIONAL
Enrollment 30 participants
Start Date 2024-07-15
Primary Completion 2024-12-30

Eligibility & Interventions

Sex All sexes
Min Age 20 Years
Max Age 40 Years
Study Type INTERVENTIONAL
Interventions
Dry NeedlingSoft Tissue Mobilization

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 30 participants in total. It began in 2024-07-15 with a primary completion date of 2024-12-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The hamstring tightness is considered as the inability to achieve knee extension greater than 160 degrees while hip is flexed at 90 degrees. When low back pain (LBP) persists for 12 weeks or longer, it is termed as chronic low back pain. The objective of study is to see the effect of dry needling versus soft tissue mobilization on hamstring muscle on pain, range of motion and functionality in patients with chronic low back pain.

Eligibility Criteria

Inclusion Criteria: * Reduction in active knee extension test \>25 * Current back pain between 4 to 6 on Numeric Pain Rating scale * Low back pain for at least 12weeks0r 6 months Exclusion Criteria: * Subjects using anticoagulants and having vascular diseases * Subjects with needle phobia and allergic to metals * Subjects with cognitive impairment * History of fracture in lumbar region * History of systemic diseases e.g. cancer or systemic joint pathologies * History of congestive heart failure in past 24 months * Subjects have used medications like narcotics or Muscle relaxants 30 days before enrolment into study

Contact & Investigator

Central Contact

Imran Amjad, Phd

✉ imran.amjad@riphah.edu.pk

📞 03324390125

Principal Investigator

Ali Raza, MS-OMPT

PRINCIPAL INVESTIGATOR

Riphah International University

Frequently Asked Questions

Who can join the NCT06751160 clinical trial?

This trial is open to participants of all sexes, aged 20 Years or older, up to 40 Years, studying Hamstring Tightness. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06751160 currently recruiting?

Yes, NCT06751160 is actively recruiting participants. Contact the research team at imran.amjad@riphah.edu.pk for enrollment information.

Where is the NCT06751160 trial being conducted?

This trial is being conducted at Lahore, Pakistan.

Who is sponsoring the NCT06751160 clinical trial?

NCT06751160 is sponsored by Riphah International University. The principal investigator is Ali Raza, MS-OMPT at Riphah International University. The trial plans to enroll 30 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology